Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Effect of Sorafenib on Molecular Biomarkers in Barrett's Esophagus With High Grade Dysplasia

NCT00619242 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00619242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Effect of Sorafenib on Molecular Biomarkers in Barrett's Esophagus With High Grade Dysplasia
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2006
Completion date
September 30, 2009
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer